Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Background: In Algeria, colorectal cancer (CRC) is the second most common cancer after lung cancer in men and breast
cancer in women. The advances of molecular genetics using molecular markers MSI, BRAF and RAS mutations can predict
prognosis and could contribute to decisions on treatment strategies.
Material & Methods: Clinico-pathological features and molecular profile of KRAS exon 2, BRAF exon 15 and MSI from 102
Algerian patients with advanced.
Results: BRAF and KRAS mutations were detected in 4.9% and 31.3% of the patients�?? tumors respectively. Activating mutation
in codon 12 and 13 in KRAS was located in the right colon (40.6% vs. 25%) in the left colon (p=0.130) which tended to be
more frequent at stage IV (55.8%) than at stage III (44.1%) (p=0, 960). Approximately 64% with KRAS mutation were well or
moderately differentiated vs. 36% (p=0, 130). The poorly differentiated amino-acid changes are more frequently observed in
codon 12 than in codon 13 and G12D is the most frequent mutation. The second is G12A. 18.6% (19/102) of the patients had
MSI-H tumors and four of the tumors MSI-H had activating V600 E BRAF mutation.
Conclusion: Most of the clinicopathologic characteristics observed in our study are similar to those reported in other studies
and further analyses in larger series are required to confirm these preliminary results. Screening program should be set up to
determine the incidence rate of the HNPCC which tend to be more frequent in Algeria than in western countries.
Biography
Relevant Topics
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals